Generate a tailored SOP for Dr. Christian Ottmann. Improve your application with a focused, well-structured draft.
Christian Ottmann is an Associate Professor of Molecular Cell Structural Biology in the Department of Biomedical Engineering at Eindhoven University of Technology (TU/e). His research focuses on small-molecule modulation of protein-protein interactions (PPIs), with a particular emphasis on stabilizing the 14-3-3 adapter protein PPIs. Throughout his career, he has been involved in early drug discovery projects within the pharmaceutical industry, targeting a wide range of diseases including various cancers, Alzheimer’s disease, inflammation, and cystic fibrosis. He has played an essential role as a coordinator for significant European projects such as the FP7 Industry-Academia Partnership Pathways (IAPP) and the Horizon2020 European Training Network (ETN) TASPPI. Dr. Ottmann aims to give back to society by addressing challenging biomedical problems through innovative approaches in drugging protein-protein interactions. He earned his diploma in Biology from Ruhr-University Bochum in Germany and completed his PhD at Eberhard-Karls-University Tübingen, graduating summa cum laude. Following his PhD, he held a postdoctoral position before founding the biotech company AmbAgon Technology. He has also been a group leader at the Chemical Genomics Centre of the Max Planck Society and has received multiple awards for his contributions to the field of medicinal chemistry, including the Innovation Award from noted chemistry societies and the Young Chemical Biologist Award from the International Chemical Biology Society (ICBS).
Eindhoven University of Technology • Eindhoven, Netherlands
Appointed Associate Professor of Molecular Structural Cell Biology in the Department of Biomedical Engineering.
Chemical Genomics Centre, Max Planck Society • Dortmund, Germany
Led a research group focused on biological chemistry and genomics.
Specific departments like Industrial Design require a portfolio. Programs like Data Science and AI require a GRE-General test for certain international backgrounds.